David Lovejoy

Plus aucun poste en cours

Fortune : 49 104 $ au 31/05/2024

Health Technology

Consumer Services

Anciens postes connus de David Lovejoy

Sociétés	Poste	Début	Fin
University of Toronto	Corporate Officer/Principal	-	-
PROTAGENIC THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	03/02/1994	-
PROTAGENIC THERAPEUTICS, INC.	Fondateur	03/02/1994	-
Protagenic Therapeutics, Inc. /Old/ Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY.	Directeur Technique/Scientifique/R&D	-	-

University of Victoria

Doctorate Degree

Internationale

Etats-Unis	3
Canada	3

Opérationnelle

Chief Tech/Sci/R&D Officer	2
Doctorate Degree	1
Corporate Officer/Principal	1

Sectorielle

Health Technology	3
Consumer Services	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
PROTAGENIC THERAPEUTICS, INC.	Health Technology

Entreprise privées	1
Protagenic Therapeutics, Inc. /Old/ Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY.	Health Technology

Entreprise privées

Health Technology